Breast-conserving surgery safety for multiple tumors in one breast
Part of Cancer, Skin clinical trials.
This trial is testing whether breast-conserving surgery (removing only the tumor and a small rim of healthy tissue) is safe when you have more than one cancer spot in the same breast. If you qualify, you would have the surgery followed by standard radiation therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with invasive breast cancer or ductal carcinoma in situ (a very early, non-spreading form of breast cancer).
- You have at least two separate cancer spots in one breast, as seen on imaging, and no cancer has spread to distant parts of your body.
- Your doctor believes all the cancer can be removed with breast-conserving surgery and that you can safely have radiation after surgery.
- Your heart, liver, kidneys, and blood system are working well enough to handle surgery and the treatments that follow.
- You are not pregnant or nursing, and you do not have inflammatory breast cancer (a rare, aggressive form).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares breast-conserving surgery (removing only the tumor and nearby tissue) to total mastectomy (removing the whole breast) for women with breast cancer in the central area of the breast. The goal is to see if the less extensive surgery works just as well.
This study compares two different surgical approaches for removing early-stage breast cancer while preserving the breast. You may qualify if you have a single, small tumor and want to keep your breast.
This trial is for women aged 55 or older with very early-stage breast cancer (stage 0 or 1) who want to save their breast. It tests giving a single dose of radiation during the lumpectomy instead of weeks of daily radiation afterward.
This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.